跳转至内容
Merck
CN

J3770

Sigma-Aldrich

JNJ7777120

≥98% (HPLC)

登录查看公司和协议定价

别名:
1-[(5-Chloro-1H-indol-2-yl)carbonyl]-4-methyl-piperazine
经验公式(希尔记法):
C14H16N3OCl
分子量:
277.75
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

检测方案

≥98% (HPLC)

形式

solid

颜色

white to off-white

溶解性

DMSO: >20 mg/mL
H2O: insoluble

创始人

Johnson & Johnson

储存温度

room temp

SMILES字符串

CN1CCN(CC1)C(=O)c2cc3cc(Cl)ccc3[nH]2

InChI

1S/C14H16ClN3O/c1-17-4-6-18(7-5-17)14(19)13-9-10-8-11(15)2-3-12(10)16-13/h2-3,8-9,16H,4-7H2,1H3

InChI key

HUQJRYMLJBBEDO-UHFFFAOYSA-N

应用

JNJ7777120 has been used as a histamine-4 receptor antagonist:
  • to study its effects on the pro-inflammatory microglia in rats
  • to study its effects on the Parkinson′s-like pathology in rat brain
  • to study its effects on the histamine receptor interaction in periodontal ligament fibroblasts (PDLF)

生化/生理作用

JNJ7777120 may exhibit neuroprotective effects against ischemic brain damage. It acts as an anti-inflammatory agent to treat inflammatory diseases. JNJ7777120 is observed to reduce colonic injury, cytokine production, and neutrophil infiltration.
JNJ7777120 is a potent, selective non-imidazole H4 histamine receptor antagonist.

特点和优势

This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Susanne Mommert et al.
International archives of allergy and immunology, 166(3), 225-230 (2015-05-01)
Natural killer (NK) cells have been detected in the lesional skin of patients with inflammatory skin diseases, where high levels of histamine are also present. Therefore, we investigated the effect of histamine, in particular via the histamine H4 receptor (H4R)
Qiuyuan Fang et al.
Brain, behavior, and immunity, 92, 127-138 (2020-11-30)
Growing evidence indicates that microglia activation and a neuroinflammatory trigger contribute to dopaminergic cell loss in Parkinson's disease (PD). Furthermore, increased density of histaminergic fibers and enhanced histamine levels have been observed in the substantia nigra of PD-postmortem brains. Histamine-induced
E Zampeli et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 58(6), 285-291 (2009-02-03)
Although the H(4) receptor localisation in the eye is unresolved, this study aimed to investigate the effects of the H(4) receptor antagonist JNJ7777120 in a model of experimental conjunctivitis. JNJ7777120, at 0.005-1 mmol/l, was instilled into the lower conjunctival fornix
Heiko Schenk et al.
Immunopharmacology and immunotoxicology, 38(5), 379-384 (2016-08-26)
The modulation of antigen uptake and activation of dendritic cells (DCs) by histamine may function as a regulator of inflammation. Therefore, we sought to determine the impact of histamine on antigen uptake by and activation of murine DCs. DCs from
Pei Zhou et al.
Brain, behavior, and immunity, 76, 61-73 (2018-11-09)
The activation of microglial cells is presumed to play a key role in the pathogenesis of Parkinson's disease (PD). The activity of microglia is regulated by the histamine-4 receptor (H4R), thus providing a novel target that may prevent the progression

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门